Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response
<i>Background and Objectives</i>: Hepatic diseases are an important public health problem. All patients with chronic hepatitis C virus (HCV) infection receive treatment, regardless of hepatic fibrosis severity. However, evaluation of hepatic fibrosis and steatosis is still useful in asse...
Guardado en:
Autores principales: | Oana Irina Gavril, Lidia Iuliana Arhire, Otilia Gavrilescu, Mihaela Dranga, Oana Barboi, Radu Sebastian Gavril, Roxana Popescu, Cristina Cijevschi Prelipcean, Anca-Victorita Trifan, Catalina Mihai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/688afb938113409696156dd118f48f7f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population
por: Muto N, et al.
Publicado: (2020) -
Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients
por: Oana Irina Gavril, et al.
Publicado: (2021) -
Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Joshua A. Levine, et al.
Publicado: (2021) -
Enzymatic Degumming of Rice Bran Oil Using Different Commercial Phospholipases and Their Cocktails
por: Mayara S. Rodrigues, et al.
Publicado: (2021) -
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable
por: Acevedo,Mónica, et al.
Publicado: (2013)